As in cell lines, FGFR3‐S249C expression conferred FGFR3 dependence on the PDX model, in which anti‐FGFR treatment with BGJ398 decreased tumor growth by 60% after 29 days of administration (Appendix Fig S2). Here, FGFR3 is linked to neoplasm.